Lung Cancer Clinical Trials 2022

Browse 219 Lung Cancer Medical Studies Across 558 Cities
40 Phase 3 Trial · 2698 Lung Cancer Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Lung Cancer Clinical Trials 2022

Reviewed by Michael Gill, B. Sc.

Image of ArriVent Investigative Site in Fairfax, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

EHR-integrated Shared Decision Making Tool And Clinical Decision Support For Lung Cancer Screeningfor Lung Cancer

This trial is designed to increase the use of low-dose CT scans to screen for lung cancer by developing and disseminating patient-centered clinical decision support tools. These tools will be integrated with electronic health records and clinical workflows, and will prompt shared decision making when patients meet screening criteria. The goal is to promote standard of care that is endorsed by the Centers for Medicare & Medicaid Services and the US Preventive Services Task Force.

Recruiting

Has No Placebo

University of Utah HealthKensaku Kawamoto, MD, PhD, MHS

Image of St. Bernards Medical Center ( Site 0089) in Jonesboro, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Pembrolizumabfor Lung Cancer

This trial will compare the efficacy of three different treatments for unresectable, locally advanced NSCLC. Arm 1 will receive pembrolizumab concurrently with chemoradiation, followed by pembrolizumab with olaparib placebo. Arm 2 will receive the same treatment as Arm 1, but will take olaparib instead of the placebo. Arm 3 will receive concurrent chemoradiation therapy followed by durvalumab. The primary hypothesis is that pembrolizumab with concurrent chemoradiation and olaparib is superior to durvalumab with respect to PFS and OS.

Phase 3

Recruiting

FDA Approved Drug

St. Bernards Medical Center ( Site 0089) (+29 Sites)Medical DirectorMerck Sharp & Dohme LLC

Image of Foothills Medical Centre in Calgary, Canada.

Phase-Based Progress Estimates

Effectiveness

Safety

Microwave Ablationfor Neoplasm Metastasis

This trial is studying a new way to treat lung cancer in patients who are not able to have surgery. The treatment is called microwave ablation and it uses high energy to kill the cancer cells. The trial will study the safety and feasibility of this treatment and if it is effective.

Phase 1 & 2

Recruiting

Has No Placebo

Foothills Medical CentreStefan J Przybojewski, MB ChB

Image of Harborview Medical Center in Seattle, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Survey-based Patient/Clinician Jumpstartfor Pneumonia, Interstitial

This trial is testing whether or not the Jumpstart intervention can improve patient-centered outcomes for those with chronic illness. The study will specifically look at Alzheimer's disease and related dementias, but will also include other common chronic illnesses. The trial will assess the efficacy of the intervention by measuring quality of care, intensity of care outcomes, and patient- and family-reported outcomes. There will also be a mixed-methods evaluation of the implementation of the intervention to explore barriers and facilitators to future implementation and dissemination.

Recruiting

Has No Placebo

Harborview Medical Center (+2 Sites)J. Randall Curtis, MD, MPH

Image of Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY in New York, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Proactive Telephone Counseling From VA Quitlinefor Tomography

This trial will evaluate if offering proactive smoking cessation support to smokers as part of participating in lung cancer screening within Veterans Health Administration is effective.

Waitlist Available

Has No Placebo

Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY (+2 Sites)Steven B. Zeliadt, PhD MPH

Image of National Institutes of Health Clinical Center in Bethesda, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

EP0057for Prostate Cancer

This trial is testing the safety and efficacy of a new drug combination to treat small cell lung cancer.

Phase 1 & 2

Recruiting

FDA Approved Drug

National Institutes of Health Clinical CenterAnish Thomas, M.D.

Image of Kaiser Permanente Southern California in Pasadena, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

More Frequent CT Surveillancefor Lung Cancer

This trial will compare two different protocols for follow-up imaging of small pulmonary nodules discovered on chest CT scans.

Waitlist Available

Has No Placebo

Kaiser Permanente Southern CaliforniaMichael K Gould, MD, MS

Image of University of Calgary in Calgary, Canada.

Phase-Based Progress Estimates

Effectiveness

Safety

Computed Tomographyfor Lung Cancer

This trial will test whether regular, low-dose CT scans can help detect and prevent lung cancer.

Waitlist Available

Has No Placebo

University of Calgary (+1 Sites)Alain Tremblay, MD

Image of University of Florida Proton Therapy Institute in Jacksonville, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Radiation With Concurrent Chemotherapyfor Lung Cancer

This trial is testing if a shorter, more intense course of radiation therapy can be as effective as the standard longer course of radiation therapy for cancer patients.

Phase 1 & 2

Waitlist Available

Has No Placebo

University of Florida Proton Therapy Institute (+6 Sites)Brad Hoppe, MD

Image of University of Texas MD Anderson Cancer Center in Houston, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Sodium Bicarbonatefor Myocardial Infarction

The goal of this clinical research study is to compare the effects of sodium bicarbonate to normal saline when used for clearing mucus blockage in patients with airway stents.

Waitlist Available

Has No Placebo

University of Texas MD Anderson Cancer CenterCarlos A. Jimenez, MD

Image of NCT00100256 in Iowa City, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Arm 1for Neoplasm Recurrence, Local

The purpose of this study is to determine the maximum dose that is safely tolerated of the experimental drug Rhenium Re 188 P2045. This will be done by first treating patients at relatively low doses of Rhenium Re 188 P2045, observing them closely to assure that there are no bad side effects, then increasing the dose when we are confident that it is safe to do so.

Phase 1 & 2

Recruiting

Has No Placebo

NCT00100256 (+1 Sites)Andarix Study DirectorAndarix Pharmaceuticals

Image of Research Site in Casa Grande, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Pemetrexedfor Lung Cancer

This trial is testing whether adding the drug vandetanib to the standard treatment for non-small cell lung cancer (NSCLC) is more effective than the standard treatment alone.

Phase 3

Waitlist Available

FDA Approved Drug

Research Site (+22 Sites)Clinical Sciences & OperationsGenzyme, a Sanofi Company

Phase-Based Progress Estimates

Effectiveness

Safety

Near Infrared Imagingfor Lung Cancers

This trial is testing if surgeons can find and remove the first lymph node that a tumor drains into. Doing this could help improve the ability to find and remove all tumor cells.

Phase 1

Waitlist Available

FDA Approved Drug

Massachusetts General Hospital (+3 Sites)Yolonda L. Colson, MD, PhD

Image of Research Site in Anaheim, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Chemotherapyfor Lung Cancer

This trial is studying osimertinib vs platinum-based doublet chemotherapy to see if they are better in treating patients with non-small cell lung cancer whose disease has progressed with previous epidermal growth factor receptor tyrosine kinase inhibitor therapy and whose tumors contain a T790M mutation.

Phase 3

Waitlist Available

FDA Approved Drug

Research Site (+26 Sites)Yilong Wu, MDAstraZeneca

Image of National Institutes of Health Clinical Center, 9000 Rockville Pike in Bethesda, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Aldesleukinfor Adenocarcinoma

This trial is testing an experimental therapy that involves taking white blood cells from patients' tumors, growing them in the laboratory in large numbers, and then giving the cells back to the patient.

Phase 2

Recruiting

FDA Approved Drug

National Institutes of Health Clinical Center, 9000 Rockville Pike (+1 Sites)James C Yang, M.D.

Image of Research Site in Chandler, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

MEDI4736for Carcinoma, Non-Small-Cell Lung

This trial will study the effects of the immunotherapy drug MEDI4736 in patients with stage III unresectable NSCLC who are also receiving concurrent chemoradiation therapy.

Phase 3

Waitlist Available

FDA Approved Drug

Research Site (+63 Sites)Phil Dennis, MDAstraZeneca

25 Lung Cancer Clinical Trials Near Me

Top Hospitals for Lung Cancer Clinical Trials

M D Anderson Cancer Center

Houston

16Active Trials

93All Time Trials for Lung Cancer

2000First Lung Cancer Trial

Memorial Sloan Kettering Cancer Center

New York

15Active Trials

121All Time Trials for Lung Cancer

1995First Lung Cancer Trial

Top Cities for Lung Cancer Clinical Trials

Boston

61Active Trials

Dana Farber Cancer InstituteTop Active Site

New York

53Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site

Lung Cancer Clinical Trials by Phase of Trial

Phase < 1 Lung Cancer Clinical Trials

2Active Lung Cancer Clinical Trials

2Number of Unique Treatments

2Number of Active Locations

Paclitaxel Vancomycin

Lung Cancer Clinical Trials 2022

Browse 219 Lung Cancer Medical Studies Across 558 Cities40 Phase 3 Trial · 2698 Lung Cancer Clinics

Furmonertinib 160 Mgfor Lung Diseases

TELESCOPE, Remote Decision Coaching With Navigation Interventionfor Lung Cancer

Furmonertinibfor Respiratory Tract Neoplasms

Olympus VE2 NIR Imaging Systemfor Lung Cancer

Transbronchial Microwave Ablationfor Lung Cancer

NCLE Aided RANB Biospyfor Lung Cancer

Pembrolizumabfor Lung Diseases

BLU-945for Cancer

Pembrolizumab/Vibostolimabfor Lung Cancer

EHR-integrated Shared Decision Making Tool And Clinical Decision Support For Lung Cancer Screeningfor Lung Cancer

Pembrolizumabfor Lung Cancer

Microwave Ablationfor Neoplasm Metastasis

Survey-based Patient/Clinician Jumpstartfor Pneumonia, Interstitial

Proactive Telephone Counseling From VA Quitlinefor Tomography

EP0057for Prostate Cancer

More Frequent CT Surveillancefor Lung Cancer

Computed Tomographyfor Lung Cancer

Radiation With Concurrent Chemotherapyfor Lung Cancer

Sodium Bicarbonatefor Myocardial Infarction

Arm 1for Neoplasm Recurrence, Local

Pemetrexedfor Lung Cancer

Near Infrared Imagingfor Lung Cancers

Chemotherapyfor Lung Cancer

Aldesleukinfor Adenocarcinoma

MEDI4736for Carcinoma, Non-Small-Cell Lung

Browse 219 Lung Cancer Medical Studies Across 558 Cities
40 Phase 3 Trial · 2698 Lung Cancer Clinics